Tech Company Financing Transactions
Metagen Therapeutics Funding Round
Mizuho Capital, Nippon Venture Capital and SMBC Venture Capital invested in a $12 million Series A venture round for Metagen Therapeutics. The round was announced on 6/15/2023.
Transaction Overview
Company Name
Announced On
6/15/2023
Transaction Type
Venture Equity
Amount
$11,986,000
Round
Series A
Proceeds Purpose
The company intends to use the funds for:1. Development and operation of the intestinal microbiota bank Development of registration system for intestinal microbiota donor candidates Operation of intestinal microbiota bank (in accordance with institutional guidelines) -- Donor recruitment/online interview, donor eligibility evaluation, intake of stool donations,manufacturing/assessment/storage of intestinal microbiota solution Establishing process regarding preparation and quality control for intestinal microbiota solution
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
246-2 Minakami Kakuganji
Tsuruoka, Yamagata, 997-0052
JP
Tsuruoka, Yamagata, 997-0052
JP
Phone
Undisclosed
Website
Email Address
Overview
Metagen Therapeutics is at the cutting edge of microbiome science Realizing innovative medicine and pharmaceuticals.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Taku Nakahara
Chief Medical Officer
Dai Ishikawa
Chief Technical Officer
Takuji Yamada
Co-Founder
Masatsugu Fukuda
Browse more venture capital transactions:
Prev: 6/15/2023: OneVest venture capital transaction
Next: 6/15/2023: Deepchecks venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs